Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL NEEDLE FREE IV CONNECTORS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NEEDLE FREE IV CONNECTORS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VALUE AND VOLUME
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL NEEDLE FREE IV CONNECTORS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. VALUE CHAIN ANALYSIS
15. HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.10 ECONOMIC DEVELOPMENT
16. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY PRODUCT
16.1 OVERVIEW
16.2 STRAIGHT CHANNEL
16.2.1 BY TUBE LUMEN
16.2.1.1. SINGLE
16.2.1.2. DOUBLE
16.2.1.3. TRIPLE
16.2.2 BY TUBE LENGTH
16.2.2.1. 10 CM
16.2.2.2. 15 CM
16.2.2.3. 30 CM
16.2.2.4. OTHERS
16.2.3 BY BORE SIZE
16.2.3.1. SMALL BORE
16.2.3.2. LARGE BORE
16.2.4 BY MATERIAL
16.2.4.1. SILICONE
16.2.4.2. PLASTIC
16.2.4.3. POLYVINYL CHLORIDE (PVC)
16.2.4.4. POLYCARBONATE OR COPOLYESTER
16.2.4.5. OTHERS
16.2.5 BY HYGEINE
16.2.5.1. STERILE
16.2.5.2. NON-STERILE
16.2.6 BY COLOUR
16.2.6.1. YELLOW
16.2.6.2. GREEN
16.2.6.3. RED
16.2.6.4. OTHERS
16.2.7 OTHERS
16.3 Y CHANNEL
16.3.1 BY TUBE LUMEN
16.3.1.1. SINGLE
16.3.1.2. DOUBLE
16.3.1.3. TRIPLE
16.3.2 BY TUBE LENGTH
16.3.2.1. 10 CM
16.3.2.2. 15 CM
16.3.2.3. 30 CM
16.3.2.4. OTHERS
16.3.3 BY BORE SIZE
16.3.3.1. SMALL BORE
16.3.3.2. LARGE BORE
16.3.4 BY MATERIAL
16.3.4.1. SILICONE
16.3.4.2. PLASTIC
16.3.4.3. POLYVINYL CHLORIDE (PVC)
16.3.4.4. POLYCARBONATE OR COPOLYESTER
16.3.4.5. OTHERS
16.3.5 BY HYGEINE
16.3.5.1. STERILE
16.3.5.2. NON-STERILE
16.3.6 BY COLOUR
16.3.6.1. YELLOW
16.3.6.2. GREEN
16.3.6.3. RED
16.3.6.4. OTHERS
16.3.7 OTHERS
16.4 T CHANNEL
16.4.1 BY TUBE LUMEN
16.4.1.1. SINGLE
16.4.1.2. DOUBLE
16.4.1.3. TRIPLE
16.4.2 BY TUBE LENGTH
16.4.2.1. 10 CM
16.4.2.2. 15 CM
16.4.2.3. 30 CM
16.4.2.4. OTHERS
16.4.3 BY BORE SIZE
16.4.3.1. SMALL BORE
16.4.3.2. LARGE BORE
16.4.4 BY MATERIAL
16.4.4.1. SILICONE
16.4.4.2. PLASTIC
16.4.4.3. POLYVINYL CHLORIDE (PVC)
16.4.4.4. POLYCARBONATE OR COPOLYESTER
16.4.4.5. OTHERS
16.4.5 BY HYGEINE
16.4.5.1. STERILE
16.4.5.2. NON-STERILE
16.4.6 BY COLOUR
16.4.6.1. YELLOW
16.4.6.2. GREEN
16.4.6.3. RED
16.4.6.4. OTHERS
16.4.7 OTHERS
16.5 MULTI CHANNEL
16.5.1 BY TUBE LUMEN
16.5.1.1. SINGLE
16.5.1.2. DOUBLE
16.5.1.3. TRIPLE
16.5.2 BY TUBE LENGTH
16.5.2.1. 10 CM
16.5.2.2. 15 CM
16.5.2.3. 30 CM
16.5.2.4. OTHERS
16.5.3 BY BORE SIZE
16.5.3.1. SMALL BORE
16.5.3.2. LARGE BORE
16.5.4 BY MATERIAL
16.5.4.1. SILICONE
16.5.4.2. PLASTIC
16.5.4.3. POLYVINYL CHLORIDE (PVC)
16.5.4.4. POLYCARBONATE OR COPOLYESTER
16.5.4.5. OTHERS
16.5.5 BY HYGEINE
16.5.5.1. STERILE
16.5.5.2. NON-STERILE
16.5.6 BY COLOUR
16.5.6.1. YELLOW
16.5.6.2. GREEN
16.5.6.3. RED
16.5.6.4. OTHERS
16.5.7 OTHERS
17. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY TYPE
17.1 OVERVIEW
17.2 POSITIVE FLUID DISPLACEMENT
17.3 NEGATIVE FLUID DISPLACEMENT
17.4 NEUTRAL FLUID DISPLACEMENT
18. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY MATERIAL
18.1 OVERVIEW
18.2 SILICONE
18.3 PLASTIC
18.4 POLYVINYL CHLORIDE (PVC)
18.5 POLYCARBONATE OR COPOLYESTER
18.6 OTHERS
19. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY HYGEINE
19.1 OVERVIEW
19.2 STERILE
19.3 NON-STERILE
20. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY PACKAGING
20.1 OVERVIEW
20.2 50/BOX
20.3 100/BOX
20.4 OTHERS
21. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY APPLICATION
21.1 OVERVIEW
21.2 UROLOGY
21.3 CARDIOLOGY
21.4 BLOOD PROCESSING
21.5 OTHERS
22. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY END USER
22.1 OVERVIEW
22.2 HOSPITALS
22.2.1 BY TYPE
22.2.1.1. PUBLIC
22.2.1.2. PRIVATE
22.2.2 BY LEVEL
22.2.2.1. TIER 1
22.2.2.2. TIER 2
22.2.2.3. TIER 3
22.3 SPECIALTY CLINICS
22.3.1 PUBLIC
22.3.2 PRIVATE
22.4 HOME CARE SETTINGS
22.5 AMBULATORY SURGICAL CENTRE
22.6 ACADEMIC AND RESEARCH INSTITUTES
22.7 OTHERS
23. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY DISTRIBUTION CHANNEL
23.1 OVERVIEW
23.2 DIRECT TENDER
23.3 RETAIL SALES
23.3.1 OFFLINE
23.3.1.1. HOSPITAL PAHRMACY
23.3.1.2. DRUGS STORES
23.3.1.3. OTHERS
23.3.2 ONLINE
23.3.2.1. E-STORES
23.3.2.2. COMPANY WEBSITE
23.3.2.3. OTHERS
23.4 OTHERS
24. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, BY GEOGRAPHY
GLOBAL NEEDLE FREE IV CONNECTORS MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 NORTH AMERICA
24.1.1 U.S.
24.1.2 CANADA
24.1.3 MEXICO
24.2 EUROPE
24.2.1 GERMANY
24.2.2 FRANCE
24.2.3 U.K.
24.2.4 ITALY
24.2.5 SPAIN
24.2.6 RUSSIA
24.2.7 TURKEY
24.2.8 BELGIUM
24.2.9 DENMARK
24.2.10 NETHERLANDS
24.2.11 SWITZERLAND
24.2.12 SWEDEN
24.2.13 POLAND
24.2.14 NORWAY
24.2.15 FINLAND
24.2.16 REST OF EUROPE
24.3 ASIA-PACIFIC
24.3.1 JAPAN
24.3.2 CHINA
24.3.3 SOUTH KOREA
24.3.4 INDIA
24.3.5 AUSTRALIA
24.3.6 NEW ZEALAND
24.3.7 SINGAPORE
24.3.8 THAILAND
24.3.9 MALAYSIA
24.3.10 VIETNAM
24.3.11 TAIWAN
24.3.12 INDONESIA
24.3.13 PHILIPPINES
24.3.14 REST OF ASIA-PACIFIC
24.4 SOUTH AMERICA
24.4.1 BRAZIL
24.4.2 ARGENTINA
24.4.3 REST OF SOUTH AMERICA
24.5 MIDDLE EAST AND AFRICA
24.5.1 SOUTH AFRICA
24.5.2 SAUDI ARABIA
24.5.3 BAHRAIN
24.5.4 UAE
24.5.5 KUWAIT
24.5.6 OMAN
24.5.7 QATAR
24.5.8 EGYPT
24.5.9 ISRAEL
24.5.10 REST OF MIDDLE EAST AND AFRICA
24.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
25. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, SWOT AND DBMR ANALYSIS
26. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, COMPANY LANDSCAPE
26.1 COMPANY SHARE ANALYSIS: GLOBAL
26.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
26.3 COMPANY SHARE ANALYSIS: EUROPE
26.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
26.5 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
26.6 MERGERS & ACQUISITIONS
26.7 NEW PRODUCT DEVELOPMENT & APPROVALS
26.8 EXPANSIONS
26.9 REGULATORY CHANGES
26.10 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
27. GLOBAL NEEDLE FREE IV CONNECTORS MARKET, COMPANY PROFILE
27.1 BD
27.1.1 COMPANY OVERVIEW
27.1.2 REVENUE ANALYSIS
27.1.3 GEOGRAPHIC PRESENCE
27.1.4 PRODUCT PORTFOLIO
27.1.5 RECENT DEVELOPMENTS
27.2 ROMSONS
27.2.1 COMPANY OVERVIEW
27.2.2 REVENUE ANALYSIS
27.2.3 GEOGRAPHIC PRESENCE
27.2.4 PRODUCT PORTFOLIO
27.2.5 RECENT DEVELOPMENTS
27.3 NP MEDICAL
27.3.1 COMPANY OVERVIEW
27.3.2 REVENUE ANALYSIS
27.3.3 GEOGRAPHIC PRESENCE
27.3.4 PRODUCT PORTFOLIO
27.3.5 RECENT DEVELOPMENTS
27.4 NORDSON CORPORATION
27.4.1 COMPANY OVERVIEW
27.4.2 REVENUE ANALYSIS
27.4.3 GEOGRAPHIC PRESENCE
27.4.4 PRODUCT PORTFOLIO
27.4.5 RECENT DEVELOPMENTS
27.5 VYGON GROUP
27.5.1 COMPANY OVERVIEW
27.5.2 REVENUE ANALYSIS
27.5.3 GEOGRAPHIC PRESENCE
27.5.4 PRODUCT PORTFOLIO
27.5.5 RECENT DEVELOPMENTS
27.6 BAIHE MEDICAL EUROPE
27.6.1 COMPANY OVERVIEW
27.6.2 REVENUE ANALYSIS
27.6.3 GEOGRAPHIC PRESENCE
27.6.4 PRODUCT PORTFOLIO
27.6.5 RECENT DEVELOPMENTS
27.7 ADVACARE PHARMA
27.7.1 COMPANY OVERVIEW
27.7.2 REVENUE ANALYSIS
27.7.3 GEOGRAPHIC PRESENCE
27.7.4 PRODUCT PORTFOLIO
27.7.5 RECENT DEVELOPMENTS
27.8 LEPU MEDICAL TECHNOLOGY(BEIJING)CO.,LTD.
27.8.1 COMPANY OVERVIEW
27.8.2 REVENUE ANALYSIS
27.8.3 GEOGRAPHIC PRESENCE
27.8.4 PRODUCT PORTFOLIO
27.8.5 RECENT DEVELOPMENTS
27.9 ICU MEDICAL , INC.
27.9.1 COMPANY OVERVIEW
27.9.2 REVENUE ANALYSIS
27.9.3 GEOGRAPHIC PRESENCE
27.9.4 PRODUCT PORTFOLIO
27.9.5 RECENT DEVELOPMENTS
27.10 POLYMEDICURE
27.10.1 COMPANY OVERVIEW
27.10.2 REVENUE ANALYSIS
27.10.3 GEOGRAPHIC PRESENCE
27.10.4 PRODUCT PORTFOLIO
27.10.5 RECENT DEVELOPMENTS
27.11 LARS MEDICARE PVT. LTD
27.11.1 COMPANY OVERVIEW
27.11.2 REVENUE ANALYSIS
27.11.3 GEOGRAPHIC PRESENCE
27.11.4 PRODUCT PORTFOLIO
27.11.5 RECENT DEVELOPMENTS
27.12 HANGZHOU FUSHAN MEDICAL APPLIANCES CO., LTD.
27.12.1 COMPANY OVERVIEW
27.12.2 REVENUE ANALYSIS
27.12.3 GEOGRAPHIC PRESENCE
27.12.4 PRODUCT PORTFOLIO
27.12.5 RECENT DEVELOPMENTS
27.13 BAXTER
27.13.1 COMPANY OVERVIEW
27.13.2 REVENUE ANALYSIS
27.13.3 GEOGRAPHIC PRESENCE
27.13.4 PRODUCT PORTFOLIO
27.13.5 RECENT DEVELOPMENTS
27.14 NEXUS MEDICAL
27.14.1 COMPANY OVERVIEW
27.14.2 REVENUE ANALYSIS
27.14.3 GEOGRAPHIC PRESENCE
27.14.4 PRODUCT PORTFOLIO
27.14.5 RECENT DEVELOPMENTS
27.15 MAIS INDIA
27.15.1 COMPANY OVERVIEW
27.15.2 REVENUE ANALYSIS
27.15.3 GEOGRAPHIC PRESENCE
27.15.4 PRODUCT PORTFOLIO
27.15.5 RECENT DEVELOPMENTS
27.16 SPARK LIFESCIENCES
27.16.1 COMPANY OVERVIEW
27.16.2 REVENUE ANALYSIS
27.16.3 GEOGRAPHIC PRESENCE
27.16.4 PRODUCT PORTFOLIO
27.16.5 RECENT DEVELOPMENTS
27.17 ASSET MEDICAL
27.17.1 COMPANY OVERVIEW
27.17.2 REVENUE ANALYSIS
27.17.3 GEOGRAPHIC PRESENCE
27.17.4 PRODUCT PORTFOLIO
27.17.5 RECENT DEVELOPMENTS
27.18 TERUMO CORPORATION
27.18.1 COMPANY OVERVIEW
27.18.2 REVENUE ANALYSIS
27.18.3 GEOGRAPHIC PRESENCE
27.18.4 PRODUCT PORTFOLIO
27.18.5 RECENT DEVELOPMENTS
27.19 RYMED TECHNOLOGIES, LLC
27.19.1 COMPANY OVERVIEW
27.19.2 REVENUE ANALYSIS
27.19.3 GEOGRAPHIC PRESENCE
27.19.4 PRODUCT PORTFOLIO
27.19.5 RECENT DEVELOPMENTS
27.20 INDOSURGICALS PRIVATE LIMITED
27.20.1 COMPANY OVERVIEW
27.20.2 REVENUE ANALYSIS
27.20.3 GEOGRAPHIC PRESENCE
27.20.4 PRODUCT PORTFOLIO
27.20.5 RECENT DEVELOPMENTS
27.21 WEIGAO MEIDCAL INTERNATIONAL CO., LTD
27.21.1 COMPANY OVERVIEW
27.21.2 REVENUE ANALYSIS
27.21.3 GEOGRAPHIC PRESENCE
27.21.4 PRODUCT PORTFOLIO
27.21.5 RECENT DEVELOPMENTS
27.22 HUBIOMED INC.
27.22.1 COMPANY OVERVIEW
27.22.2 REVENUE ANALYSIS
27.22.3 GEOGRAPHIC PRESENCE
27.22.4 PRODUCT PORTFOLIO
27.22.5 RECENT DEVELOPMENTS
27.23 KINDLY(KDL) MEDITECH
27.23.1 COMPANY OVERVIEW
27.23.2 REVENUE ANALYSIS
27.23.3 GEOGRAPHIC PRESENCE
27.23.4 PRODUCT PORTFOLIO
27.23.5 RECENT DEVELOPMENTS
27.24 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
27.24.1 COMPANY OVERVIEW
27.24.2 REVENUE ANALYSIS
27.24.3 GEOGRAPHIC PRESENCE
27.24.4 PRODUCT PORTFOLIO
27.24.5 RECENT DEVELOPMENTS
27.25 KAPSAM HEALTH PRODUCTS
27.25.1 COMPANY OVERVIEW
27.25.2 REVENUE ANALYSIS
27.25.3 GEOGRAPHIC PRESENCE
27.25.4 PRODUCT PORTFOLIO
27.25.5 RECENT DEVELOPMENTS
27.26 HALKEY-ROBERTS CORPORATION
27.26.1 COMPANY OVERVIEW
27.26.2 REVENUE ANALYSIS
27.26.3 GEOGRAPHIC PRESENCE
27.26.4 PRODUCT PORTFOLIO
27.26.5 RECENT DEVELOPMENTS
27.27 EIB CO., LTD
27.27.1 COMPANY OVERVIEW
27.27.2 REVENUE ANALYSIS
27.27.3 GEOGRAPHIC PRESENCE
27.27.4 PRODUCT PORTFOLIO
27.27.5 RECENT DEVELOPMENTS
27.28 MEDIPLUS LTD.
27.28.1 COMPANY OVERVIEW
27.28.2 REVENUE ANALYSIS
27.28.3 GEOGRAPHIC PRESENCE
27.28.4 PRODUCT PORTFOLIO
27.28.5 RECENT DEVELOPMENTS
28. RELATED REPORT
29. CONCLUSION
30. QUESTIONNAIRE
31. ABOUT DATA BRIDGE MARKET RESEARCH
